PHASE IB DOSE-ESCALATION STUDY OF BEZ235 OR BKM120 IN COMBINATION WITH PACLITAXEL (PTX) IN PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Dirix, L. [1 ]
Schuler, M. [2 ]
Machiels, J. [3 ]
Hess, D. [4 ]
Awada, A. [5 ]
Steeghs, N. [6 ]
Paz-Ares, L. [7 ]
von Moos, R. [8 ]
Rabault, B. [9 ]
Rodon, J. [10 ]
机构：
[1] Sint Augustinus Hosp, Antwerp, Belgium
[2] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Essen, Germany
[3] Clin Univ St Luc, Dept Med Oncol, B-1200 Brussels, Belgium
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[6] Netherlands Canc Inst, Amsterdam, Netherlands
[7] Univ Hosp Virgen del Rocio, Seville, Spain
[8] Kantonsspital Graubunden, Chur, Switzerland
[9] Novartis Pharma AG, Oncol, Basel, Switzerland
[10] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [21] A Dose-Escalation Study with a Special Drug Delivery System (SDS) of BEZ235, a Novel Dual PI3K/mTOR Inhibitor, in Patients with Metastatic/Advanced Solid Tumors
    Rodon, J.
    Infante, J.
    Burris, H.
    Tabernero, J.
    Ranson, M. R.
    Rouyrre, N.
    Duval, V.
    Silva, A.
    Hackl, W.
    Baselga, J.
    CANCER RESEARCH, 2010, 70
  • [22] A phase I/IB dose-escalation study of BEZ235 in combination with trastuzumab in patients with PI3-kinase or PTEN altered HER2+metastatic breast cancer.
    Krop, Ian E.
    Saura, Cristina
    Ahnert, Jordi Rodon
    Becerra, Carlos
    Britten, Carolyn D.
    Isakoff, Steven J.
    Demanse, David
    Hackl, Wolfgang
    Quadt, Cornelia
    Silva, Antonio P.
    Burris, Howard A.
    Abu-Khalaf, Maysa M.
    Baselga, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Phase I dose-escalation study of brostallicin in combination with cisplatin (cDDP) in patients with advanced solid tumors
    Lorusso, D.
    Fornari, G.
    Caponigro, F.
    Quirino, M.
    Merlano, M.
    Airoldi, M.
    Schena, M.
    Jannuzzo, M. G.
    Crippa, S.
    Scambia, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 112
  • [24] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    A. Craig Lockhart
    Shankar Sundaram
    John Sarantopoulos
    Monica M. Mita
    Andrea Wang-Gillam
    Jennifer L. Moseley
    Stephanie L. Barber
    Alex R. Lane
    Claudine Wack
    Laurent Kassalow
    Jean-François Dedieu
    Alain C. Mita
    Investigational New Drugs, 2014, 32 : 1236 - 1245
  • [25] A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
    Jeffrey R. Infante
    Roger B. Cohen
    Kevin B. Kim
    Howard A. Burris
    Gregory Curt
    Ugochi Emeribe
    Delyth Clemett
    Helen K. Tomkinson
    Patricia M. LoRusso
    Investigational New Drugs, 2017, 35 : 576 - 588
  • [26] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    Lockhart, A. Craig
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Wang-Gillam, Andrea
    Moseley, Jennifer L.
    Barber, Stephanie L.
    Lane, Alex R.
    Wack, Claudine
    Kassalow, Laurent
    Dedieu, Jean-Francois
    Mita, Alain C.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1236 - 1245
  • [27] Phase I Dose-Escalation Study of Intravenous Aflibercept in Combination with Docetaxel in Patients with Advanced Solid Tumors
    Isambert, Nicolas
    Freyer, Gilles
    Zanetta, Sylvie
    You, Benoit
    Fumoleau, Pierre
    Falandry, Claire
    Favier, Laure
    Assadourian, Sylvie
    Soussan-Lazard, Karen
    Ziti-Ljajic, Samira
    Trillet-Lenoir, Veronique
    CLINICAL CANCER RESEARCH, 2012, 18 (06) : 1743 - 1750
  • [28] A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors
    Infante, Jeffrey R.
    Cohen, Roger B.
    Kim, Kevin B.
    Burris, Howard A., III
    Curt, Gregory
    Emeribe, Ugochi
    Clemett, Delyth
    Tomkinson, Helen K.
    LoRusso, Patricia M.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (05) : 576 - 588
  • [29] A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors
    LoRusso, Patricia M.
    Infante, Jeffrey R.
    Kim, Kevin B.
    Burris, Howard A., III
    Curt, Gregory
    Emeribe, Ugochi
    Clemett, Delyth
    Tomkinson, Helen K.
    Cohen, Roger B.
    BMC CANCER, 2017, 17
  • [30] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
12345